Vifor Pharma Faces Antitrust Investigation by EU Commission

Vifor Pharma Faces Antitrust Investigation by EU Commission

Swiss pharmaceutical company Vifor Pharma is facing a formal antitrust investigation by the European Commission on the suspicion that the company may have restricted competition by illegally disparaging its closest – and potentially only – competitor in Europe on the market for intravenous iron treatment, Pharmacosmos and its iron-deficiency treatment, Monofer.

Vifor Pharma’s conduct appears to be aimed at hindering competition against its blockbuster high-dose intravenous iron treatment medicine, Ferinject.

A statement issued by the Commission outlines it has indications that for many years, Vifor Pharma may have been disparaging Monofer by spreading misleading information regarding its safety. The Commission is concerned that Vifor Pharma pursued a misleading communication campaign, primarily targeting healthcare professionals, which may have unduly hindered Monofer’s uptake in the European Economic Area (EEA). Approximately 1.8 million patients suffering from iron deficiency are currently being treated with high-dose intravenous iron products annually in the EEA.

The investigation follows a complaint filed with the Commission by Pharmacosmos.

Vifor Pharma is a global pharmaceutical company headquartered in Switzerland and operating from several subsidiaries in the EEA while Pharmacosmos is a smaller Danish family-owned specialist pharmaceutical company focused notably on the treatment of iron deficiency conditions.

EU Commission Executive Vice-President Margrethe Vestager, in charge of competition policy, said, “Competition in the pharmaceutical sector is important. It provides access to affordable and innovative medicines to patients. The dissemination of misleading information regarding the safety of Pharmacosmos’ iron deficiency treatment, Monofer, may have delayed its uptake. This would ultimately harm patients by stifling competition from an innovative medicine. Today we launched an in-depth investigation to assess whether this is the case”.

In a statement Vifor Pharma said, ‘We are fully cooperating with the European Commission during this process and are convinced that we have not engaged in any anti-competitive behaviour.’

It was announced in March, that Vifor Pharma is being acquired by Australian biotechnology leader CSL Limited.

This is the EU Commission’s second formal investigation into potential abuses relating to exclusionary disparagement of competing products in the pharmaceutical industry. In March 2021, the Commission opened a formal investigation into possible anticompetitive conduct of Teva in relation to a blockbuster multiple sclerosis medicine.

Image by Dimitrisvetsikas/Via Pixabay/https://pixabay.com/service/license/

 

Antoinette Tyrrell is a writer and journalist who started her career in print and broadcast journalism in Ireland. An English and History graduate of the National University of Ireland, Maynooth, she worked for 11 years in corporate public relations for Irish Government bodies in the Foreign Direct Investment and Energy sectors.

She is the founder of GoWrite, a business writing and public relations consultancy. Her work has appeared in a range of national and international media and trade publications. She is also a traditionally published novelist of commercial fiction.

newsletter
Join our mailing list and never miss an update !
Planning Permission Granted for Project to Enable Exchange of Irish and French Electricity

Planning Permission Granted for Project to Enable Exchange of Irish and French Electricity

EirGrid, operator of Ireland’s electricity grid, has welcomed a decision by An Bord Pleanála, Ireland’s national planning body, to grant approval for the Celtic Interconnector Project, subject to a number

14.9 Million Excess Deaths Associated With the COVID-19 Pandemic in 2020 and 2021

14.9 Million Excess Deaths Associated With the COVID-19 Pandemic in 2020 and 2021

New estimates from the World Health Organization (WHO) show that the full death toll associated directly or indirectly with the COVID-19 pandemic between 1 January 2020 and 31 December 2021

Pepco Group Pledges Price Protection for European Consumers

Pepco Group Pledges Price Protection for European Consumers

The fast-growing pan-European variety discount retailer, Pepco Group, owner of the PEPCO and Dealz brands in Europe and Poundland in the UK, is reporting strong strategic progress and trading growth